IgE Antibody (4G7) [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # NB500-471JF549
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Flow Cytometry
Label
Janelia Fluor 549
Antibody Source
Monoclonal Mouse IgG Clone # 4G7
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for IgE Antibody (4G7) [Janelia Fluor® 549]
Immunogen
Purified human IgE
Specificity
The antibody 4G7 reacts with human IgE; it recognizes an epitope different from the ones recognized by BE5 and 4H10 antibodies to IgE.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG
Applications for IgE Antibody (4G7) [Janelia Fluor® 549]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Multi-step
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IgE
Long Name
Immunoglobulin E
Alternate Names
IgE, immunoglobulin heavy constant epsilon
Gene Symbol
IGHE
Additional IgE Products
Product Documents for IgE Antibody (4G7) [Janelia Fluor® 549]
Product Specific Notices for IgE Antibody (4G7) [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...